Both keynote speakers have both played pivotal roles over the past year; Andy as an entrepreneur and investor with a track record in founding and scaling up innovative biotech and health-tech companies and Ian as manufacturing lead for the UK’s vaccine task force.
One year on, Bio Integrates 2021 is an opportunity to reflect on how life science companies have responded to the pandemic, look forward to the future as we adjust to a changing landscape and re-connect to build a plan for tomorrow.
Bio Integrates 2021 presents a unique opportunity for delegates to engage with top executives in biotech, CDMOs, supply chain, funding and investment; all of whom are involved with the development of therapies for the future. This distinguished one-day conference will take place online with delegates able to utilise presentations and online features including a virtual exhibition hall.
“The past 12 months have highlighted the importance of collaboration to get new treatments to patients fast.” Says Co-Founder and Executive Director, Samuel Thangiah.
“Thanks to excellent collaboration between government, industry and academia, we have a roadmap out of the pandemic. Bio Integrates provides a platform for us all to recognise and value our collaborative spirit; a forum to spark fresh ideas and encourage new partnerships which will ensure that new therapies and technologies continue to reach patients faster.”
Christopher Watt, Co-Founder & Executive Director comments: “As well as our keynote speakers, we will be bringing you a line-up of over 70 experts, covering three core themes: Connection, Reflection and Projection; including Emmanual Ligner, President and CEO at Cytiva and Eliot Forster, Chief Executive Officer at F-Star Therapeutics”
“Our Connection track focuses on finding the right investors, partners and vendors, as well as offering top tips on how to develop and sustain connections. The Reflection track is particularly important as we look at how the biotech ecosystem has changed. The projection track looks to the future, to discuss what the life science funding and infrastructure landscape will look like and the impact of Brexit.”
“I have to say that I have never been part of such a brilliantly organised event. I had not really appreciated the number of Tech strands you were bringing together in a virtual world; a whole different thing to the events we were all used to.” Giovanna Forte, Forte Medical about Bio Integrates 2020.
For further information, contact:
Paula Burton / Stephanie Wenban
T: +44 (0)20 3405 7892
Notes to Editors
About our keynote speakers and organisers:
Ian McCubbin OBE
Ian has been leading manufacturing for the Vaccines Task Force since its formation in May 2020.
Prior to that, he led an Industry Advisory Group formed by the BioIndustry Association. Ian is a pharmacist by training and has more than 35 years’ experience in Pharmaceutical Manufacturing and Supply Chain recently retiring as Senior Vice President Global Supply GSK.
He is currently Chairman of Roslin CT, a contract cell therapy development and manufacturing company in Edinburgh. He also Chairs the Manufacturing Advisory Board for UKRI Life Science Challenge Project.
Dr Andy Richards CBE
Andy is an entrepreneur and investor with an established track record in founding and scaling up innovative life-science, biotechnology and digital health companies in the UK. He is currently Chairman of Congenica, Abcodia, Closed Loop Medicine, Arecor and Ieso Digital Health and is a Director of Owlstone Medical and Cancer Research Technology (the commercial board of CRUK). He is an advisor to several investment funds including Cambridge Innovation Capital and the UCL Technology Fund, is Chair of the CRUK Seed Fund and is a director of the Scale-Up Institute. He is also a council member of the MRC and continues to have an active interest in the evolution of the Babraham Research Campus.
Andy is a Cambridge Graduate with a PhD in Chemistry and an early career spanning positions with ICI (now AstraZeneca) and PA Technology. He was a founder and executive director of Chiroscience plc until its merger with Celltech in 1999 and since that time he has founded, invested in and helped to scale more than 25 innovative ventures including companies such as Vectura, Arakis, Cambridge Biotechnology Ltd and Geneservice. Andy is also a founder member of the Cambridge Angels.
Andy is passionate about science and the translation of science to do good for society. The life-sciences and healthcare sectors provide the perfect arena for translating science into technology that can help people around the world. He received a CBE for services to the life-sciences in 2015.
About Life Science Integrates
Formed in 2011 by Christopher Watt and Samuel Thangiah, Life Science Integrates (LSI) brings together senior leaders from across the Life Sciences, including industry, academia, government and regulators; providing them with unique opportunities to be part of the conversations that set out the industry’s challenges and identify effective strategies and solutions.